The Role of Alternatively spliced Fibroblast Growth Factor Receptor 2 Isoforms in Breast Cancer
Recent genome-wide association studies identified FGFR2 as one of breast cancer susceptibility genes. FGFR2 expression was down-regulated in breast carcinomas when compared with paired normal epithelium. Stable retroviral transduction of FGFR2-IIIb and its alternatively spliced FGFR2-IIIc variants w...
Main Author: | Wei, Wangzhi |
---|---|
Other Authors: | Ezzat, Shereen |
Language: | en_ca |
Published: |
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/1807/31636 |
Similar Items
-
The Role of Alternatively spliced Fibroblast Growth Factor Receptor 2 Isoforms in Breast Cancer
by: Wei, Wangzhi
Published: (2011) -
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
by: Navid Sobhani, et al.
Published: (2018-07-01) -
The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments
by: Navid Sobhani, et al.
Published: (2020-03-01) -
Fibroblast growth factor receptor 1 protein (FGFR1) as potential prognostic and predictive marker in patients with luminal B breast cancers overexpressing human epidermal receptor 2 protein (HER2)
by: Belhadj Amina, et al.
Published: (2021-01-01) -
Expression of fibroblast growth factor receptor and its role in regulating osteoblast differentiation
by: MO Qifei, et al.
Published: (2019-12-01)